BiotechTubeBiotechTube
Home/Shoulder Innovations/Matthew Ahearn
MA

Matthew Ahearn

Chief Operating Officer

Shoulder Innovations

Therapeutic Areas

OrthopedicsMusculoskeletal

Shoulder Innovations Pipeline

DrugIndicationPhase
InSet® GlenoidOsteoarthritis of the shoulder; Primary Total Shoulder Arthroplasty (TSA)Approved
InSet® ReverseRotator Cuff Tear Arthropathy; Massive Cuff Tears; Revision ArthroplastyApproved
InSet® Total Shoulder SystemComprehensive system for Anatomic and Reverse Shoulder ArthroplastyApproved
Custom Glenoid ImplantsSevere glenoid bone deficiency in shoulder arthroplastyApproved

Leadership Team at Shoulder Innovations

RB
Robert Ball
CEO & Executive Chairman
JP
Jeffrey Points
Chief Financial Officer
DB
David Blue
Chief Customer Experience Officer
JO
Jon Osborne
Vice-President, Commercial Development
View full Shoulder Innovations profile